These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 5382731

  • 1. [Immunosuppressive properties of a new cytostatic agent of beta-chloroethylene series, spirazidine].
    Ado VA, Podkolzin AA, Vermel' AE.
    Sov Med; 1969 Oct; 32(10):31-4. PubMed ID: 5382731
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of anaphylactic shock and bronchial asthma with spirazidin in experimental and clinical conditions].
    Ado VA, Podkolzin AA, Vermel' AE.
    Vrach Delo; 1969 Aug; 8():45-7. PubMed ID: 5382485
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [On the inhibition of the delayed-type allergic reactions by spirazidine].
    Beslekoev TI, Podkolzin AA, Ado VA.
    Farmakol Toksikol; 1968 Aug; 31(4):441-4. PubMed ID: 5698135
    [No Abstract] [Full Text] [Related]

  • 5. [Depression of immunity reaction by immunodepressants].
    Ado VA, Podkolzin AA, Goriachkina LA.
    Farmakol Toksikol; 1970 Aug; 33(3):322-4. PubMed ID: 4247651
    [No Abstract] [Full Text] [Related]

  • 6. [Suppression of experimental contact dermatitis in guinea pigs with spirazidin].
    Ado VA.
    Biull Eksp Biol Med; 1968 Jan; 65(1):48-9. PubMed ID: 5652287
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Suppression of allergic reactions with spirazidin].
    Ado VA.
    Patol Fiziol Eksp Ter; 1969 Jan; 13(6):60-2. PubMed ID: 5377080
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antianaphylactic and antiasthmatic properties of new piperazinyl 7-(beta-hydroxypropyl)-theophylline derivatives in guinea pigs.
    Czarnecki R, Librowski T, Pawłowski M.
    Pol J Pharmacol; 2001 Jan; 53(2):131-6. PubMed ID: 11787952
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical evaluation of the antitumor effectiveness of spirobromine].
    Borisov VI, Chernov VA, Dement'eva NP, Korobkova LI, Bogdanova NV.
    Sov Med; 1987 Jan; (12):42-3. PubMed ID: 3445176
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Study of intra-venous fensperide in reversible obstructive ventilatory disorders. Measurement of parameters of respiratory mechanics].
    Galy P, Brune J, Dorsit G, Wiessandanger T.
    Rev Lyon Med; 1970 May 15; 19(9):395-8. PubMed ID: 5455185
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Clinical study of fenspiride in asthma and dyspneic chronic bronchopneumopathies].
    Pernod J, Batime J.
    J Fr Med Chir Thorac; 1970 May 15; 24(7):783-8. PubMed ID: 5491638
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Phase II trial of spirogermanium for treatment of advanced breast cancer.
    Falkson G, Falkson HC.
    Cancer Treat Rep; 1983 Feb 15; 67(2):189-90. PubMed ID: 6825129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.